How Gene Therapy Will Move Rare Disease Research at Warp Speed
There is great potential for research surrounding rare diseases. Uncover various types of gene delivery and its impact on diverse populations in the U.S.
Leading CRO Accelerates Startup with Integrated, Centralized IRB/IBC Reviews
Advarra’s integrated central IRB and IBC review services helped Parexel accelerate the delivery of life-saving and innovative gene therapies.
QMS for Artificial Intelligence
Discover how Advarra's ReadyQMS program transformed a biotech startup's quality and compliance, driving success.
Unlocking Study Activation: 2023 Study Activation Report
Access the survey report now for current perspectives on study startup activities impacted by rapidly evolving technology and tools.
Clinical Research Training: A Blended Approach
Listen now and hear how this approach accelerated the learning curve and fostered a productive environment for integrating the OnCore CTMS.
Biotech Organization Partners with Advarra to Become Inspection Ready
A biotech organization becomes inspection ready through Advarra's GxP services and successful U.S. Food and Drug Administration guidance.
Reducing Site Burden Throughout Study Startup
Learn strategies to streamline workflows across sites and sponsors, and explore success stories on how to reduce site burden.
Decentralized Clinical Trials and Regulatory Changes
We discuss the evolution of decentralized trial modalities and possible solutions to regulatory challenges.
In this podcast, we discuss our predictions and perspectives on the 2023 clinical research trends.
Embracing Changes to the Clinical Research Workforce
In this episode, we discuss workforce challenges in the clinical research industry and the impact of the great resignation.
My Favorite Case Study: COVID-19 Applications for Monkeypox
How the COVID-19 pandemic has shaped vaccine development, promoting accelerated research for conditions like monkeypox.
Data on the go: Mobile Application Considerations for Clinical Trials and Beyond
Find out the necessary regulatory and ethical considerations when utilizing an app or connected device in human subjects research.